The CXCR4/SDF-1 Chemokine Axis: A Potential Therapeutic Target for Bone Metastases?

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|16|11|1284-1290

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.11, 2010-04, pp. : 1284-1290

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chemokines and their Receptors as Therapeutic Targets: The Role of the SDF-1 / CXCR4 Axis

By  

Current Pharmaceutical Design, Vol. 10, Iss. 11, 2004-04 ,pp. : 1245-1259

Bentham Science Publishers

Access to resources Recommend Favorite

The Chemokine Receptor CXCR4 as a Therapeutic Target for Several Diseases

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 9, 2006-09 ,pp. : 989-995

Bentham Science Publishers

Access to resources Recommend Favorite

The CXCL12/CXCR4 Axis as a Therapeutic Target in Cancer and HIV-1 Infection

By  

Current Medicinal Chemistry, Vol. 18, Iss. 4, 2011-02 ,pp. : 497-512

Bentham Science Publishers

Access to resources Recommend Favorite

Rational Design of Chemokine SDF-1 Analogs with Agonist Activity for the CXCR4 Receptor and the Capacity to Rapidly Mobilize PMN and Hematopoietic Progenitor Cells in Mice

By  

Letters in Drug Design & Discovery, Vol. 1, Iss. 2, 2004-04 ,pp. : 126-134

Bentham Science Publishers

Access to resources Recommend Favorite

TGF-&bgr; Pathway as a Therapeutic Target in Bone Metastases

By  

Current Pharmaceutical Design, Vol. 16, Iss. 11, 2010-04 ,pp. : 1301-1312

Bentham Science Publishers

Access to resources Recommend Favorite